会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • IMMUNOMODULATING DIMERS
    • 免疫调节二聚体
    • WO1997044351A1
    • 1997-11-27
    • PCT/US1997008689
    • 1997-05-22
    • THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY
    • THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITYCLAYBERGER, CarolKRENSKY, Alan, M.BEULOW, Roland
    • C07K07/00
    • C07K14/70539A61K38/00
    • Peptide-like compounds and their variants having immunomodulating activity including the N-terminal acylated and/or C-terminal amidated or esterified forms thereof of up 60 amino acids wherein the peptide-type compound comprises the formula alpha - beta wherein: alpha and beta are the same or different and are of the formula: (a) {R aa L} (aa ) or (b) (aa ) {L aa R} wherein: aa is E or V; aa is D, S or N; aa is R or G; aa is I or N; aa is a hydrophobic or small amino acid; aa is R or L; aa is G or R; aa is a hydrophobic or small amino acid; wherein the sequence in the brackets may optionally be absent or truncated at any peptide type bond within the brackets. Said compounds may be used by themselves or in combination with immunosuppressant drugs, to reduce CTL activation, particularly in association with transplantation.
    • 肽类化合物及其变体具有免疫调节活性,包括60个氨基酸的N-末端酰化和/或C末端酰胺化或酯化形式,其中肽型化合物包含式α-β,其中:α和β为 相同或不同,具有下式:(a){R aa <76-77> L}(aa <79-84>)或(b)(aa <84-79>){L aa <77-76 > R}其中:aa 76是E或V; aa <77>是D,S或N; aa <79>是R或G; aa <80>是I或N; aa <81>是疏水或小氨基酸; aa <82>是R或L; aa 83是G或R; aa <84>是疏水或小氨基酸; 其中括号中的序列可以任选地在括号内的任何肽类型键处不存在或截短。 所述化合物可以自身使用或与免疫抑制剂药物组合使用,以减少CTL活化,特别是与移植有关。